Johnson & Johnson's COVID-19 Vaccine Is Linked To A Rare Neurological Disorder

Around 12.8 million people have received J&J's one-dose vaccine in the United States.

According to the FDA, there have been about 100 preliminary reports of vaccine-related GBS, including 95 serious cases that required hospitalization and one reported death. According to a statement from the U.S. Centers for Disease Control and Prevention (CDC), most of the cases were in men, many of whom were 50 or older and most of the patients developed GBS two weeks after getting vaccinated.